Cemiplimab trials for Melanoma
All Cemiplimab trials · All Melanoma trials
7
Recruiting trials
Phase breakdown
Phase 1 3Phase 2 4Phase 3 2
Recruiting trials studying Cemiplimab for Melanoma
- A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
- A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
- Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
Common questions
How many trials study Cemiplimab for Melanoma?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.